SLC44A2 and deep vein thrombosis: It has been found that Slc44a2 is involved in the direct adhesion and activation of neutrophils to vWF and that Slc44a2/HNA-3a plays an important role in the adhesion and activation of venous neutrophils under inflammation and specific shear (188), highlighting the potential of Slc44a2 as an adjuvant therapeutic target for DVT.